Breakthrough infection after three vaccines resulted in stronger circulating IgA responses than a fourth vaccine dose (median OD ± IQR, 1.20, 0.89–1.71 vs. 0.39, 0.26–0.61, p < 0.0001, Figure 3a). The gene discussed is CD79A; the disease is infection.